Circulation

Efficacy of Suppression of Serum Transthyretin With Patisiran and Vutrisiran in Variant ATTR Amyloidosis: An Observational Crossover Study

Y Yousuf Razvi (National Amyloidosis Centre, University College London, Royal Free Hospital, London, United Kingdom.) M Muhammad Umaid Rauf (National Amyloidosis Centre, University College London, Royal Free Hospital, London, United Kingdom.) A Aldostefano Porcari (National Amyloidosis Centre, University College London, Royal Free Hospital, London, United Kingdom.) J Josephine Mansell (National Amyloidosis Centre, University College London, Royal Free Hospital, London, United Kingdom.) A Awais Sheikh (National Amyloidosis Centre, University College London, Royal Free Hospital, London, United Kingdom.) A Adam Ioannou (National Amyloidosis Centre, University College London, Royal Free Hospital, London, United Kingdom.) C Carol J. Whelan (National Amyloidosis Centre, University College London, Royal Free Hospital, London, United Kingdom.) L Lucia Venneri (National Amyloidosis Centre, University College London, Royal Free Hospital, London, United Kingdom.) A Ana Martinez-Naharro (National Amyloidosis Centre, University College London, Royal Free Hospital, London, United Kingdom.) D David F. Hutt (National Amyloidosis Centre, University College London, Royal Free Hospital, London, United Kingdom.) D Dorota Rowczenio (National Amyloidosis Centre, University College London, Royal Free Hospital, London, United Kingdom.) J Janet A. Gilbertson (National Amyloidosis Centre, University College London, Royal Free Hospital, London, United Kingdom.) A Ashutosh D. Wechalekar (National Amyloidosis Centre, University College London, Royal Free Hospital, London, United Kingdom.) H Helen J. Lachmann (National Amyloidosis Centre, University College London, Royal Free Hospital, London, United Kingdom.) P Philip N. Hawkins (National Amyloidosis Centre, University College London, Royal Free Hospital, London, United Kingdom.) M Marianna Fontana (National Amyloidosis Centre, University College London, Royal Free Hospital, London, United Kingdom.) J Julian D. Gillmore (University College London, National Amyloidosis Centre, Royal Free Hospital, London)
View Original
APA MLA Chicago BibTeX RIS

Article Details

Journal Circulation
Volume / Issue Vol. 153, Issue 5
Published February 03, 2026
Pages 364-366
ISSN 0009-7322
Publisher Lippincott Williams & Wilkins

Journal Info

Circulation

Lippincott Williams & Wilkins
ISSN: 0009-7322 Health Sciences

Authors (17)

Y

Yousuf Razvi

National Amyloidosis Centre, University College London, Royal Free Hospital, London, United Kingdom.

M

Muhammad Umaid Rauf

National Amyloidosis Centre, University College London, Royal Free Hospital, London, United Kingdom.

A

Aldostefano Porcari

National Amyloidosis Centre, University College London, Royal Free Hospital, London, United Kingdom.

J

Josephine Mansell

National Amyloidosis Centre, University College London, Royal Free Hospital, London, United Kingdom.

A

Awais Sheikh

National Amyloidosis Centre, University College London, Royal Free Hospital, London, United Kingdom.

A

Adam Ioannou

National Amyloidosis Centre, University College London, Royal Free Hospital, London, United Kingdom.

C

Carol J. Whelan

National Amyloidosis Centre, University College London, Royal Free Hospital, London, United Kingdom.

L

Lucia Venneri

National Amyloidosis Centre, University College London, Royal Free Hospital, London, United Kingdom.

A

Ana Martinez-Naharro

National Amyloidosis Centre, University College London, Royal Free Hospital, London, United Kingdom.

D

David F. Hutt

National Amyloidosis Centre, University College London, Royal Free Hospital, London, United Kingdom.

D

Dorota Rowczenio

National Amyloidosis Centre, University College London, Royal Free Hospital, London, United Kingdom.

J

Janet A. Gilbertson

National Amyloidosis Centre, University College London, Royal Free Hospital, London, United Kingdom.

A

Ashutosh D. Wechalekar

National Amyloidosis Centre, University College London, Royal Free Hospital, London, United Kingdom.

H

Helen J. Lachmann

National Amyloidosis Centre, University College London, Royal Free Hospital, London, United Kingdom.

P

Philip N. Hawkins

National Amyloidosis Centre, University College London, Royal Free Hospital, London, United Kingdom.

M

Marianna Fontana

National Amyloidosis Centre, University College London, Royal Free Hospital, London, United Kingdom.

J

Julian D. Gillmore

University College London, National Amyloidosis Centre, Royal Free Hospital, London

Related Articles from this Journal

Occupational Radiation Safety in Electrophysiology During Pregnancy: Evaluating Uterine Radiation Doses During Catheter Ablations and Device Implantations

Johanna Mueller-Leisse, Henrike Aenne Katrin Hillmann et al. Aug 2026 10.1161/circulationaha.126.080556

Response by Rogers et al to Letter Regarding, “Deep Learning-Based Continuous QT Monitoring to Identify High-Risk Prolongation Events After Class III Antiarrhythmic Initiation”

Albert J. Rogers, Sabyasachi Bandyopadhyay et al. Aug 2026 10.1161/circulationaha.126.080755

Clinical Cardiology at the Crossroads: Perspectives on the Next Era at <i>Circulation</i>

Jennifer E. Ho, Ryan J. Tedford Aug 2026 10.1161/circulationaha.126.080205

ABHD11-Mediated mtDNA Transcription Restored Mitochondrial Function to Attenuate Cardiomyocyte Ferroptosis After Myocardial Infarction

Yu Liu, Yijin Chen et al. Aug 2026 10.1161/circulationaha.125.078593

Letter by Li et al Regarding Article, “Deep Learning-Based Continuous QT Monitoring to Identify High-Risk Prolongation Events After Class III Antiarrhythmic Initiation”

Dong Li, Shuang Zhang et al. Aug 2026 10.1161/circulationaha.126.079996